This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04205/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04205/identifier/pubchem-compound/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04205/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04205/identifier/drugbank/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04205
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB04205 n10:DB04205
dcterms:title
Thymidine-3',5'-Diphosphate
adms:identifier
n7:DB04205 n11:46509069 n12:PTP n13:25021187
n3:IUPAC-Name
n4:271B441F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4425-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4424-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4421-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4422-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4423-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B441D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B441B-363D-11E5-9242-09173F13E4C5 n4:271B441E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B441C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B442B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B442C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4426-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4427-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4429-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4428-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B442A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4431-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4433-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4434-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4430-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B442F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4432-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4420-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B442D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B442E-363D-11E5-9242-09173F13E4C5